U.S Government Socks Away The Entire Supply Of Remdesivir, A Drug That May Work For COVID-19 Treatment
As the world witnesses, the ground-breaking success of the new drug in the laboratory called remdesivir, America doesn’t take much time to seize the worldwide supply of the drug and starts stocking up. Remdesivir is seen as the potential medicine against the Coronavirus. It has been tested on critical patients of COVID-19 and the experiments have worked. As soon as it starts getting a positive response, the United States buys up all the stocks of the breakthrough medical substance, leaving very little percentage for Canada and the rest of the world.
The Department of Health and Human Services (HHS) has already announced officially on Monday that there would be approximately 500,000 treatment courses of the drug available for the American COVID-19 patients in all the hospitals within September. The United States has bought the whole stack of the drug from its only manufacturer Gilead Sciences. Each treatment course will require 5 to 6 vials of remdesivir.
It is obtained from a reliable news source that the president has decided to buy a plethora of remdesivir that includes 100 percent of Gilead’s projected production for July, 90 percent of August’s production, and 90 percent of production through September. There will more clinical trials coming for drug use.
Alex Azar, the HHS Secretary is happy with the prognostic decision taken by the U.S President Donald Trump that ensures Americans to have the first authorized therapeutic for COVID-19. He calls it “an amazing deal” to save millions of Americans from the deadly grasp of the novel virus.
Alex Azar has added to his statement that the U.S government will do anything possible to keep the patients safe with remdesivir from the loaded stock.
The U.S. Food and Drug Administration assured Gilead with the emergency use authorization in the month of May after the U.S. National Institutes of Health found recovery reports of 19 patients who were suffering from a critical condition in the hospital.
In April, it was revealed by the U.S.-based company 3M that the Trump administration ordered them to cut the supply of N95 masks to Canada. Now the president has bought 90 percent of the new drug that can treat Coronavirus, making a difficult reality for Canada and the rest of the world.
Related Posts :